- Home
- TRNR vs SCNI Comparison
TRNR vs SCNI Comparison
Compare TRNR & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TRNR | SCNI |
|---|---|---|
| Founded | 2017 | 2003 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Appliances | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3M | 1.2M |
| IPO Year | 2023 | 2014 |
Fundamental Metrics
Financial Performance| Metric | TRNR | SCNI |
|---|---|---|
| Price | $3.17 | $0.24 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 200.4K | 136.9K |
| Earning Date | 05-18-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 50.00 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $11,530,000.00 | N/A |
| Revenue This Year | $264.92 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 114.31 | N/A |
| 52 Week Low | $0.19 | $0.21 |
| 52 Week High | $5.65 | $3.47 |
Technical Indicators
Market Signals| Indicator | TRNR | SCNI |
|---|---|---|
| Relative Strength Index (RSI) | 58.41 | 43.60 |
| Support Level | $2.24 | $0.23 |
| Resistance Level | $5.49 | $0.28 |
| Average True Range (ATR) | 0.35 | 0.03 |
| MACD | -0.07 | 0.01 |
| Stochastic Oscillator | 44.67 | 70.45 |
Price Performance
Historical ComparisonAbout TRNR Interactive Strength Inc.
Interactive Strength Inc provides an integrated home fitness platform that allows its customers to participate in interactive wellness and strength-based training sessions. Its health coaching services encompass guidance and coaching on nutrition, recovery, sleep, and other health and lifestyle categories. The company generates revenue from sales of its connected fitness products, membership revenue, and personal training revenue.
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units: (i) Scinai R&D, focused on the development of therapeutics in inflammation and immunology, and (ii) the contract development and manufacturing organization (CDMO) business. The CDMO business provides integrated development and manufacturing services to small and emerging biotech companies, supporting clients from early-stage development through clinical-stage production.